D-dimer testing measures fragments produced when blood clots break down and can help assess patients with increased clotting activity.
The development of Accela and NeoArc involved collaboration with an advisory group comprising several cancer research and treatment institutions.
The CE-IVDR-certified test is designed to detect three diabetes-associated autoantibodies (AAbs) that can indicate an increased risk of developing T1D.
Anaconda is targeting the large vessel occlusion stroke market, where mechanical thrombectomy is used to remove blood clots from blocked cerebral arteries.
The ACUVUE OASYS MAX 2 Week lens is part of the wider ACUVUE OASYS MAX portfolio, which J&J developed to provide advanced options for people who use reusable contact lenses.
The Photon Counting Sensor Fab is the only facility of its kind in Europe and will produce semiconductor sensors used in advanced X-ray imaging.
The expanded facility will allow Siemens Healthineers to increase production of its PET detector technology and respond to growing demand from healthcare providers.
The acquisition brings MLM’s laboratory infrastructure and scientific expertise into Labcorp’s global network, creating a broader platform to support clinical trials across multiple regions.
Nyxoah plans to enrol and implant up to 229 patients at as many as 25 sites, with participants receiving follow-up for up to five years after implantation.
The software supports K-wire placement for pedicle screws by combining preoperative computed tomography (CT) or intraoperative cone-beam CT (CBCT) images with real-time X-ray images.